A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes

Inclusion Criteria: * Adult subjects with hypertension, either newly diagnosed or treated but currently uncontrolled as defined by Joint National Committee (JNC) 7 for subjects with Type 2 diabetes mellitus (T2DM) (that is, greater than or equal to \[\>=\] 130/80 mmHg) * Aged at least 18 years old * Diagnosed with T2DM and already on anti-diabetic therapy, and with glycosylated hemoglobin of less than 7 percent Exclusion Criteria: * Subjects who were already on beta-blocker therapy at the time of recruitment * Subjects with heart rate of at most 60 beats per minute (bpm) at rest * Subjects with secondary hypertension, congenital heart disease, coronary artery disease, peripheral arterial disease or congestive heart failure in any stage * Subjects with coronary conduction disorders (bundle branch block) * Subjects with signs of definitive target organ damage consistent with World Health Organization (WHO) Stage III or with severe renal or hepatic disease * Subjects who are pregnant or expect to be pregnant within the 24-week study period * Subjects on oral contraceptives * Subjects with asthma or a history of asthma * Subjects with documented severe renal disease * Subjects on anti-neoplastic drugs